Cochrane · systematic review · CD013158

Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome

Sibrecht, G, Kearl, CR, Borys, F, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library

NeonatalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
4
No studies
3
Included studies
NR
No studies 3 · 42.9%Ungraded 0 · 0%Very low 1 · 14.3%Low 3 · 42.9%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Surfactant treatment guided by rapid tests for surfactant deficiency versus surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

Population: preterm infants at risk of respiratory distress syndrome
7 questions
OutcomeEffectEvidenceStatus / GRADE
Neonatal mortality (mortality < 28 days of age) from any cause ‐ not reported
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria
no estimate extractedNRNo studies
Mortality prior to hospital discharge№ of participants: 562 (3 RCTs)
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria
RR 1.25 [0.65, 2.41]NRVery low
Downgraded: inconsistency
Bronchopulmonary dysplasia№ of participants: 562(3 RCTs)
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria
RR 0.9 [0.61, 1.32]NRLow
Bronchopulmonary dysplasia or mortality ‐ not reported
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria
no estimate extractedNRNo studies
Surfactant utilization № of participants: 562 (3 RCTs)
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria
RR 0.97 [0.85, 1.11]NRLow
Downgraded: inconsistency
Any pneumothorax№ of participants: 506(2 RCTs)
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria
RR 0.53 [0.15, 1.92]NRLow
Neurodevelopmental outcome at approximately two years' corrected age ‐ not reported
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria
no estimate extractedNRNo studies